Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $414.8300 (1.16%) ($407.5600 - $415.8900) on Tue. Apr. 2, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.76% (three month average) | RSI | 53 | Latest Price | $414.8300(1.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.5% a day on average for past five trading days. | Weekly Trend | REGN advances 0.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(59%) XLV(48%) IVW(40%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.88% in a week (0% probabilities). UUP(-11%) VXX(-10%) TLT(-6%) IFRA(-6%) TIP(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.88% (StdDev 1.76%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
5 Day Moving Average | $408.7(1.5%) | 10 Day Moving Average | $404.7(2.5%) | 20 Day Moving Average | $407.61(1.77%) | To recent high | -5.6% | To recent low | 11.5% | Market Cap | $43.984b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |